Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2005-11-17 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RENNES (35000), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BOUSTIE-DHALEINE : revenue, balance sheet and financial ratios
PHARMACIE BOUSTIE-DHALEINE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RENNES (35000),
this company of category PME
shows in 2023 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOUSTIE-DHALEINE (SIREN 485155394)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
1 387 134 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
50 696 €
37 264 €
64 644 €
77 678 €
436 634 €
47 889 €
85 650 €
64 570 €
-123 261 €
-148 166 €
188 671 €
EBITDA
N/C
N/C
95 651 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
4.7%
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE BOUSTIE-DHALEINE generates positive net income of 51 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2025: 189 k€ -> 51 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
50 696 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 78%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
77.796%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.216%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
478.216
-1362.923
-1525.874
69805.352
994.983
610.623
133.871
109.042
105.229
92.956
77.796
Financial autonomy
15.938
-7.085
-6.129
0.123
7.945
12.084
37.596
42.037
43.578
45.595
49.216
Repayment capacity
None
None
None
None
None
None
None
None
9.86
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
5.492%
None%
None%
Sector positioning
Debt ratio
77.82025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE BOUSTIE-DHALEINE (77.80) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.22%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE BOUSTIE-DHALEINE (49.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
9.86 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE BOUSTIE-DHALEINE (9.86) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 155.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
121.221
118.372
108.952
115.726
147.143
156.986
151.631
157.236
172.765
162.544
155.246
Interest coverage
None
None
None
None
None
None
None
None
3.654
None
None
Sector positioning
Liquidity ratio
155.252025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BOUSTIE-DHALEINE (155.25) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
3.65x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE BOUSTIE-DHALEINE (3.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BOUSTIE-DHALEINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
134 871 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
26
0
0
Customer payment term (days)
0
0
0
0
0
0
0
0
8
0
0
Supplier payment term (days)
0
0
0
0
0
0
0
0
49
0
0
Positioning of PHARMACIE BOUSTIE-DHALEINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BOUSTIE-DHALEINE is estimated at
805 311 €
(range 546 488€ - 1 263 645€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
546k€805k€1263k€
805 311 €Range: 546 488€ - 1 263 645€
NAF 5 année 2025
Valuation method used
Net Income Multiple
50 696 €
×
15.9x
=805 312 €
Range: 546 489€ - 1 263 645€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOUSTIE-DHALEINE with other companies in the same sector:
Frequently asked questions about PHARMACIE BOUSTIE-DHALEINE
What is the revenue of PHARMACIE BOUSTIE-DHALEINE ?
The revenue of PHARMACIE BOUSTIE-DHALEINE in 2023 is 1.4 M€.
Is PHARMACIE BOUSTIE-DHALEINE profitable?
Yes, PHARMACIE BOUSTIE-DHALEINE generated a net profit of 51 k€ in 2025.
Where is the headquarters of PHARMACIE BOUSTIE-DHALEINE ?
The headquarters of PHARMACIE BOUSTIE-DHALEINE is located in RENNES (35000), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE BOUSTIE-DHALEINE ?
The tax return of PHARMACIE BOUSTIE-DHALEINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOUSTIE-DHALEINE operate?
PHARMACIE BOUSTIE-DHALEINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart